Ignite Creation Date:
2024-05-06 @ 11:42 AM
Last Modification Date:
2024-10-26 @ 12:49 PM
Study NCT ID:
NCT03584165
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-06-07
First Post:
2018-06-29
Brief Title:
Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa
Sponsor:
NightstaRx Ltd a Biogen Company
Organization:
Biogen